Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Increased abundance of opioid receptor heteromers after chronic morphine administration.

Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA.

Sci Signal. 2010 Jul 20;3(131):ra54. doi: 10.1126/scisignal.2000807.

2.

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function.

Tiyerili V, Zimmer S, Jung S, Wassmann K, Naehle CP, Lütjohann D, Zimmer A, Nickenig G, Wassmann S.

Basic Res Cardiol. 2010 Jul;105(4):465-77. doi: 10.1007/s00395-010-0090-7. Epub 2010 Apr 2.

PMID:
20361197
3.

Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration.

Rives ML, Vol C, Fukazawa Y, Tinel N, Trinquet E, Ayoub MA, Shigemoto R, Pin JP, Prézeau L.

EMBO J. 2009 Aug 5;28(15):2195-208. doi: 10.1038/emboj.2009.177. Epub 2009 Jul 9.

4.

Renin-angiotensin system in the pathogenesis of liver fibrosis.

Pereira RM, dos Santos RA, da Costa Dias FL, Teixeira MM, Simões e Silva AC.

World J Gastroenterol. 2009 Jun 7;15(21):2579-86. Review.

5.

Novel endogenous peptide agonists of cannabinoid receptors.

Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, Devi LA.

FASEB J. 2009 Sep;23(9):3020-9. doi: 10.1096/fj.09-132142. Epub 2009 Apr 20.

6.

Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.

Urtasun R, Cubero FJ, Vera M, Nieto N.

Gastroenterology. 2009 Apr;136(4):1410-22, e1-4. doi: 10.1053/j.gastro.2008.12.065. Epub 2009 Jan 6.

PMID:
19250650
7.

Neuro2A differentiation by Galphai/o pathway.

Ma'ayan A, Jenkins SL, Barash A, Iyengar R.

Sci Signal. 2009 Jan 20;2(54):cm1. doi: 10.1126/scisignal.254cm1. Review.

8.

Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?

Kunos G, Osei-Hyiaman D, Bátkai S, Sharkey KA, Makriyannis A.

Trends Pharmacol Sci. 2009 Jan;30(1):1-7. doi: 10.1016/j.tips.2008.10.001. Epub 2008 Nov 29. Review.

10.

Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.

Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE, Patterson AJ, Anderson JP, Tsao PS, Lenardo MJ, Ashley EA, Quertermous T.

J Clin Invest. 2008 Oct;118(10):3343-54. doi: 10.1172/JCI34871.

11.

Endocannabinoids and the control of energy homeostasis.

Kunos G, Osei-Hyiaman D, Liu J, Godlewski G, Bátkai S.

J Biol Chem. 2008 Nov 28;283(48):33021-5. doi: 10.1074/jbc.R800012200. Epub 2008 Aug 11. Review.

12.

Role of angiotensin II AT1 receptor activation in cardiovascular diseases.

Billet S, Aguilar F, Baudry C, Clauser E.

Kidney Int. 2008 Dec;74(11):1379-84. doi: 10.1038/ki.2008.358. Epub 2008 Jul 23. Review.

13.

Liver cirrhosis.

Schuppan D, Afdhal NH.

Lancet. 2008 Mar 8;371(9615):838-51. doi: 10.1016/S0140-6736(08)60383-9. Review.

14.

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Jeong WI, Osei-Hyiaman D, Park O, Liu J, Bátkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G.

Cell Metab. 2008 Mar;7(3):227-35. doi: 10.1016/j.cmet.2007.12.007.

15.

Identification of a serotonin/glutamate receptor complex implicated in psychosis.

González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC.

Nature. 2008 Mar 6;452(7183):93-7. doi: 10.1038/nature06612. Epub 2008 Feb 24.

16.

Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.

Rozenfeld R, Devi LA.

FASEB J. 2008 Jul;22(7):2311-22. doi: 10.1096/fj.07-102731. Epub 2008 Feb 11.

17.

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Friedman SL.

Physiol Rev. 2008 Jan;88(1):125-72. doi: 10.1152/physrev.00013.2007. Review.

18.

Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.

Billet S, Bardin S, Verp S, Baudrie V, Michaud A, Conchon S, Muffat-Joly M, Escoubet B, Souil E, Hamard G, Bernstein KE, Gasc JM, Elghozi JL, Corvol P, Clauser E.

J Clin Invest. 2007 Jul;117(7):1914-25.

20.

Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids.

Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, Müller C, Woods AS, Hope BT, Ciruela F, Casadó V, Canela EI, Lluis C, Goldberg SR, Moratalla R, Franco R, Ferré S.

Neuropsychopharmacology. 2007 Nov;32(11):2249-59. Epub 2007 Mar 14.

Supplemental Content

Support Center